Paysign Inc
paysign.comWhat Do They Do?
Provides prepaid card products and processing services for businesses, consumers and government entities. Also provides software for blood and plasma collection organizations.
10-K for FY2025, filed Mar 25, 2026
How Do They Make Money?
Paysign earns cardholder fees per transaction and bills program sponsors monthly for card-management and claims-processing services. It earns interchange when card transactions are processed, typically settled within a few days, and also earns a portion of unused card balances over card life and unspent balances when cards or programs expire.
10-K for FY2025, filed Mar 25, 2026Plasma and pharma program revenues include both fixed and variable components. Cardholder fees represent an obligation to the cardholder…View ↗
The portion of the dollar value of prepaid-stored value cards that consumers do not ultimately redeem are referred to as breakage. In…View ↗
The Company utilizes the remote method of revenue recognition for settlement income whereby the unspent card balances will be recognized as…View ↗
$82M
-
10-K for FY2025, filed Mar 25, 2026
$82M ↗
Who Are Their Customers?
Businesses and government entities use Paysign's prepaid programs for rewards, rebates, patient assistance and public payments; the company markets payment solutions directly through its sales team. Its debit-card account product is promoted to existing cardholders through existing communication channels.
10-K for FY2025, filed Mar 25, 2026Paysign, Inc. (the “Company,” “Paysign,” “we” or “our”), headquartered in Nevada, was incorporated on August 24, 1995, and trades under the…View ↗
Government-Funded Programs: The government prepaid category consists of products such as Social Security benefits, veterans’ benefits…View ↗
Our Paysign solutions for the pharmaceutical industry are a specialized, adjudicated solution that pays all or a portion of a patient’s…View ↗
We market our Paysign payment solutions through direct marketing by the Company’s sales team. Our primary market focus is on companies that…View ↗
We market our Paysign Premier product through existing communication channels to a targeted segment of our existing cardholders, as well as…View ↗
Do Revenues Turn Into Profits?
Yes. It kept 9 cents of every revenue dollar as net income in FY2025 and turned 62 cents into free cash flow.
10-K for FY2025, filed Mar 25, 2026
$7.4MView ↗
10-K for FY2025, filed Mar 25, 2026
$7.6MView ↗
10-K for FY2025, filed Mar 25, 2026
$51.2MView ↗
How Are They Changing?
-
Aug 5, 2026
Raises full-year outlook
Raised 2026 revenue outlook to $114.0 million to $117.0 million and Adjusted EBITDA outlook to $35.0 million to $38.0 million.
Sources
8-K, filed Aug 5, 2026
Raising full-year 2026 outlook – revenue $114.0 million to $117.0 million; Adjusted EBITDA $35.0 million to $38.0 million 1Adjusted EBITDA…View ↗
Growing. Revenue grew 2.8x in 4 years, from $29.5M in FY2021 to $82M in FY2025, about 29% a year.
Life-science software
The earlier report describes prepaid card products and processing; the latest report also describes Apherion software for blood and plasma collection organizations.
10-K for FY2022, filed Mar 22, 2023 10-K for FY2025, filed Mar 25, 2026
Loading...
